RU2012131290A - Выявление риска возникновения преэклампсии - Google Patents

Выявление риска возникновения преэклампсии Download PDF

Info

Publication number
RU2012131290A
RU2012131290A RU2012131290/15A RU2012131290A RU2012131290A RU 2012131290 A RU2012131290 A RU 2012131290A RU 2012131290/15 A RU2012131290/15 A RU 2012131290/15A RU 2012131290 A RU2012131290 A RU 2012131290A RU 2012131290 A RU2012131290 A RU 2012131290A
Authority
RU
Russia
Prior art keywords
acid
concentration
hydroxytryptophan
preeclampsia
risk
Prior art date
Application number
RU2012131290/15A
Other languages
English (en)
Russian (ru)
Inventor
Луис КЕННИ
БЕЙКЕР Филипп НЬЮТОН
Дэвид БРОАДХЕРСТ
Original Assignee
Юниверсити Колледж Корк, Нэшнл Юниверсити Оф Айеленд, Корк
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Юниверсити Колледж Корк, Нэшнл Юниверсити Оф Айеленд, Корк filed Critical Юниверсити Колледж Корк, Нэшнл Юниверсити Оф Айеленд, Корк
Publication of RU2012131290A publication Critical patent/RU2012131290A/ru

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/493—Physical analysis of biological material of liquid biological material urine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/689—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to pregnancy or the gonads
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
    • G16B40/10—Signal processing, e.g. from mass spectrometry [MS] or from PCR
    • G—PHYSICS
    • G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
    • G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
    • G16B99/00—Subject matter not provided for in other groups of this subclass
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/36—Gynecology or obstetrics
    • G01N2800/368—Pregnancy complicated by disease or abnormalities of pregnancy, e.g. preeclampsia, preterm labour
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medical Informatics (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Spectroscopy & Molecular Physics (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Evolutionary Biology (AREA)
  • Theoretical Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Databases & Information Systems (AREA)
  • Artificial Intelligence (AREA)
  • Software Systems (AREA)
  • Evolutionary Computation (AREA)
  • Epidemiology (AREA)
  • Data Mining & Analysis (AREA)
  • Computer Vision & Pattern Recognition (AREA)
  • Bioethics (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
RU2012131290/15A 2009-12-21 2010-12-21 Выявление риска возникновения преэклампсии RU2012131290A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28846509P 2009-12-21 2009-12-21
US61/288,465 2009-12-21
PCT/EP2010/070446 WO2011080170A1 (en) 2009-12-21 2010-12-21 Detection of risk of pre-eclampsia

Publications (1)

Publication Number Publication Date
RU2012131290A true RU2012131290A (ru) 2014-01-27

Family

ID=43587630

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2012131290/15A RU2012131290A (ru) 2009-12-21 2010-12-21 Выявление риска возникновения преэклампсии

Country Status (8)

Country Link
US (3) US9262582B2 (https=)
EP (3) EP3206033A1 (https=)
JP (3) JP5756125B2 (https=)
CN (1) CN102893156A (https=)
BR (1) BR112012016918A2 (https=)
ES (1) ES2970328T3 (https=)
RU (1) RU2012131290A (https=)
WO (2) WO2011080170A1 (https=)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2638785C1 (ru) * 2016-12-12 2017-12-15 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ прогнозирования риска развития преэклампсии тяжелого течения

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102893156A (zh) * 2009-12-21 2013-01-23 爱尔兰国立科克大学 子痫前期风险的检测
IN2014CN03826A (https=) * 2011-11-30 2015-10-16 Koninkl Philips Nv
US20150087553A1 (en) * 2012-04-13 2015-03-26 Bioscreening and Diagnostics, LLC Early trimester screening for early- and late-onset preeclampsia
MX356775B (es) * 2012-06-27 2018-06-13 Hoffmann La Roche Medios y metodos que aplican sflt-1/plgf o relacion de endoglina/plgf para descartar el inicio de preeclampsia en un determinado periodo de tiempo.
CN103513042A (zh) * 2013-09-23 2014-01-15 中国科学院动物研究所 用于预测或早期诊断妊娠高血压疾病的试剂盒
US20170205420A1 (en) * 2014-06-23 2017-07-20 Wallac Oy Biochemical markers for use in determining risk of diabetes
RU2558465C1 (ru) * 2014-07-15 2015-08-10 Государственное бюджетное образовательное учреждение высшего профессионального образования Читинская государственная медицинская академия Министерства здравоохранения РФ Способ доклинической диагностики преэклампсии
US20170299607A1 (en) * 2014-09-24 2017-10-19 Map Ip Holding Limited Methods For Providing A Prognosis Of Pregnancy
US20180114600A1 (en) * 2015-03-23 2018-04-26 Adelaide Research & Innovation Pty Ltd Methods and systems for determining risk of a pregnancy complication occurring
AU2016344373A1 (en) * 2015-10-26 2018-05-24 Brigham Young University Serum lipid biomarkers of preeclampsia
GB201600882D0 (en) 2016-01-18 2016-03-02 Power Box Ag Improvements to router apparatus
US20170299612A1 (en) * 2016-04-13 2017-10-19 Abbott Laboratories Cardiac troponin i detection during pregnancy for cardiovascular disease identification and risk assessment
US10978202B2 (en) * 2016-04-21 2021-04-13 Perigen Inc. Method and system for concurrently monitoring multiple obstetrics patients
US11682495B2 (en) * 2016-10-13 2023-06-20 Carnegie Mellon University Structured medical data classification system for monitoring and remediating treatment risks
CN106755492B (zh) * 2017-01-24 2020-04-21 深圳金蕊科技有限公司 用于预测子痫前期的成套snp及其应用
WO2018174876A1 (en) * 2017-03-22 2018-09-27 Mprobe Inc. Methods and compositions for providing a preeclampsia assessment with metabolites
JP2018175850A (ja) * 2017-04-14 2018-11-15 株式会社Ｎｔｔドコモ データ収集装置及びデータ収集方法
JP2019041754A (ja) * 2017-08-31 2019-03-22 株式会社Ｎｔｔドコモ 予測装置及び予測方法
US11341138B2 (en) * 2017-12-06 2022-05-24 International Business Machines Corporation Method and system for query performance prediction
EP3750168B1 (en) * 2018-02-09 2025-11-19 Metabolomic Diagnostics Limited A system and method of generating a model to detect, or predict the risk of, an outcome
GB201802123D0 (en) 2018-02-09 2018-03-28 Metabolomic Diagnostics Ltd A method of processomg a biological sample
BR112020016085A2 (pt) * 2018-02-09 2020-12-15 Metabolomic Diagnostics Limited Métodos de previsão de nascimento prematuro a partir de pré-eclâmpsia usando biomarcadores metabólicos e proteicos
JP7013416B2 (ja) * 2018-06-21 2022-01-31 マルハニチロ株式会社 腎機能維持及び保護剤、並びに、その効果評価方法
WO2019244140A1 (ja) * 2018-06-21 2019-12-26 マルハニチロ株式会社 腎機能維持及び保護剤、並びに、その効果評価方法
CN112673259B (zh) * 2018-07-20 2024-11-22 豪夫迈·罗氏有限公司 基于igfbp-7的先兆子痫预测
AU2020213872A1 (en) * 2019-01-29 2021-08-12 Metabolomic Diagnostics Limited Detection of risk of pre-eclampsia in obese pregnant women
KR102308865B1 (ko) * 2019-02-08 2021-10-05 서울대학교산학협력단 전신 홍반 루푸스 산모의 임신 위험도를 평가하는 방법
CA3144694A1 (en) 2019-07-25 2021-01-28 Jose A. Horcajadas Identification of viable human embryos
CN110534184B (zh) * 2019-08-29 2022-07-15 中国人民解放军陆军军医大学第一附属医院 一种产科手术资源配置预测系统
CN110806456B (zh) * 2019-11-12 2022-03-15 浙江工业大学 一种UPLC-HRMS Profile模式非靶向代谢轮廓数据自动解析的方法
AU2021225366A1 (en) * 2020-02-28 2022-10-06 Metabolomic Diagnostics Limited Prediction of risk of pre-eclampsia
CN112820406A (zh) * 2020-12-30 2021-05-18 复旦大学附属妇产科医院 一种妊娠早期对子痫前期发病风险的预测方法
CN113092777B (zh) * 2021-03-26 2023-11-14 泰达国际心血管病医院 孕早期进行重症子痫前期患者筛查的方法
KR102366856B1 (ko) * 2021-04-23 2022-02-23 이화여자대학교 산학협력단 레티노이드 대사체를 이용한 조산의 조기 예측 방법
CN117233367B (zh) * 2023-11-16 2024-02-09 哈尔滨脉图精准技术有限公司 妊娠期高血压风险评估的代谢标志物
CN118518860B (zh) * 2024-04-16 2025-06-10 山东第一医科大学(山东省医学科学院) 用于诊断或预警急性冠脉综合征的生物标志物及其筛选方法和应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030068653A1 (en) * 2000-06-01 2003-04-10 Parrott Jeff A. Determining existence of complications in pregnancies by measuring levels of bioactive lipids
DE10043124A1 (de) * 2000-08-31 2002-03-14 Max Delbrueck Centrum Verfahren zur Diagnostik von neuronalen Erkrankungen sowie zur Behandlung der defizienten primären Hämostase
WO2006086731A2 (en) * 2005-02-09 2006-08-17 The Gov't.T Of The Usa As Represented By The Secretary Of The Department Of Health & Human Services Method for identifying the risk of preterm delivery
US20080255764A1 (en) * 2005-09-12 2008-10-16 Phenomenome Discoveries Inc. Methods for the Diagnosis of Colorectal Cancer and Ovarian Cancer by the Measurement of Vitamin E-Related Metabolites
CA2644499A1 (en) * 2006-03-02 2007-09-13 Perkinelmer Las, Inc. Methods for distinguishing isomers using mass spectrometry
GB0612669D0 (en) * 2006-06-27 2006-08-09 Univ Leeds Biomarkers for preeclampsia
GB0613165D0 (en) * 2006-06-28 2006-08-09 Univ Warwick Real-time infrared measurement and imaging system
US20080071151A1 (en) * 2006-06-30 2008-03-20 Sogin David C Method and Apparatus for Diagnosing Pre-eclampsia
CN101122600A (zh) * 2007-08-16 2008-02-13 复旦大学附属中山医院 一种血清小分子代谢产物的检测方法
CN102893156A (zh) * 2009-12-21 2013-01-23 爱尔兰国立科克大学 子痫前期风险的检测

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2638785C1 (ru) * 2016-12-12 2017-12-15 Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет" (НИУ "БелГУ") Способ прогнозирования риска развития преэклампсии тяжелого течения

Also Published As

Publication number Publication date
US20160223517A1 (en) 2016-08-04
WO2011080170A1 (en) 2011-07-07
JP2016014685A (ja) 2016-01-28
JP2013515255A (ja) 2013-05-02
EP3206033A1 (en) 2017-08-16
EP3422006A1 (en) 2019-01-02
US9262582B2 (en) 2016-02-16
EP2517019A1 (en) 2012-10-31
WO2011080170A9 (en) 2012-07-12
WO2011075842A1 (en) 2011-06-30
JP2015038512A (ja) 2015-02-26
JP5815830B2 (ja) 2015-11-17
US20130073212A1 (en) 2013-03-21
JP6185532B2 (ja) 2017-08-23
JP5756125B2 (ja) 2015-07-29
US20190056380A1 (en) 2019-02-21
ES2970328T3 (es) 2024-05-28
CN102893156A (zh) 2013-01-23
EP3422006B1 (en) 2023-11-01
US10564146B2 (en) 2020-02-18
BR112012016918A2 (pt) 2016-04-12
EP3422006C0 (en) 2023-11-01

Similar Documents

Publication Publication Date Title
RU2012131290A (ru) Выявление риска возникновения преэклампсии
Moreno et al. Non-invasive diagnosis and biomarkers in alcohol-related liver disease
JP2015038512A5 (https=)
EP1633244A2 (en) Apparatus and method for risk stratification of patients with chest pain of suspected cardiac origin
Longini et al. Proton nuclear magnetic resonance spectroscopy of urine samples in preterm asphyctic newborn: a metabolomic approach
Lippi et al. Blood glucose determination: effect of tube additives
Guha et al. Noninvasive assessment of liver fibrosis: serum markers, imaging, and other modalities
CN117074698B (zh) 用于急性心肌梗死早期诊断的标志物组合、试剂盒、系统和用途
Benton et al. Andree Gruslin award lecture: Metabolomics as an important modality to better understand preeclampsia
Deraz et al. Assessment of ventricular dysfunction in Egyptian children with Beta-thalassemia major
Ter Horst et al. Pulse oximetry beyond oxygen saturation: Early waveform characteristics in sepsis patients with adverse outcomes-A proof-of-concept study
Chi et al. Association of left ventricular structural and functional abnormalities with aortic and brachial blood pressure variability in hypertensive patients: the SAFAR study
Hirashima et al. A novel three-step approach for predicting the imminent onset of preeclampsia within 4 weeks after blood sampling at 19–31 weeks of gestation
Wiśniewski et al. Urinary F2-Isoprostane Concentration as a Poor Prognostic Factor After Subarachnoid Hemorrhage.
RU2618443C1 (ru) Способ прогнозирования риска развития атеросклеротических изменений сосудов у европеоидов
Hu et al. Evaluating eight indicators for identifying metabolic syndrome in Chinese and American adolescents
Singh et al. Correlating objective echocardiographic parameters in patients with pulmonary hypertension due to bronchopulmonary dysplasia
CN120048503A (zh) 一种基于代谢组学的子痫前期风险评估预测模型及其应用
CN116959672A (zh) 一种恶性肿瘤受测者术后睡眠障碍监测方法
RU2705911C1 (ru) Способ диагностики когнитивной дисфункции у пациентов с сахарным диабетом 1 типа методом протонной магнитно-резонансной спектроскопии
Geneş et al. Subclinical myocardial dysfunction detected by speckletracking in asymptomatic individuals with exerciseinduced premature ventricular complexes
Bhuwapathanapun et al. Serum-free placental growth factor isoform 1 at 11–13-week gestation: effects of maternal factors, mean arterial pressure, placental volume, and uterine artery pulsatility index
Kim et al. Intraplaque hemorrhage volume in patients with carotid atherosclerosis: How informative is it?
US20250367658A1 (en) Systems And Methods For Semi-Quantitative And Quantitative Detection Of Metabolities Of Progesterone
KR102697110B1 (ko) 대사산물을 검출하기 위한 방법 및 소비자 제품

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20160114